헬스케어용 로보틱 프로세스 자동화(RPA) : 시장 인사이트, 경쟁 구도 및 시장 예측(2034년)

RPA in Healthcare Market Summary

Overview:

• The global RPA in healthcare market was valued at USD 2,745.12 million in 2025 and is projected to reach USD 14,562.17 million by 2034.
• The market is expected to expand at a CAGR of 20.37% during the forecast period 2026-2034, supported by the rising need for operational efficiency, healthcare labor shortages, the increasing digitization of healthcare services, and demand for cost reduction in administrative tasks.
• By type, the software segment dominated the RPA in healthcare market with a 74% share in 2025.
• By application, the claims management segment dominated the RPA in healthcare market with a 33% share in 2025.
• By end-user, the healthcare providers segment dominated the RPA in healthcare market with a 55% share in 2025.
• North America accounted for the largest share of the RPA in healthcare market at 40% in 2025, while Asia-Pacific is anticipated to register the fastest growth through 2034.

Robotic Process Automation (RPA) in healthcare is the use of software robots, or bots, to automate the routine, repetitive, and rule-based tasks that fill healthcare administrative and operational workflows, such as data entry, billing, scheduling, and claims processing. These bots mimic human actions on digital systems, aiming to enhance efficiency, minimize manual errors, and enable healthcare workers to devote more attention to patient care. The market is organized by the type of offering supplied, the application automated, and the organization that adopts it. By type, it is divided between the software licenses that provide the automation platform and the services, including implementation, support and maintenance, and training and consulting, that surround them. By application, it spans the front-office, mid-office, and back-office processes of healthcare, including patient scheduling and registration, claims management, billing and revenue cycle management, electronic health record management and coding, and regulatory and compliance documentation. By end-user, it spans the healthcare providers that deliver care, the healthcare payers that administer insurance, and the pharmaceutical and life sciences companies that manage regulatory, pharmacovigilance, and clinical trial workflows. The market has accelerated since the COVID-19 pandemic, and it is increasingly defined by the convergence of RPA with artificial intelligence, machine learning, and natural language processing into intelligent automation and hyperautomation, in which bots handle unstructured data and cognitive tasks, and by the shift toward cloud-based and low-code platforms.

RPA in Healthcare Market Key Growth Drivers

• The rising need for administrative efficiency and cost reduction, since hospitals and clinics are burdened with time-consuming data entry, claims processing, and billing that RPA reduces while improving accuracy.
• Healthcare labor shortages and burnout, with the World Health Organization projecting a shortfall of some 11 million health workers by 2030, driving demand for digital assistants to handle repetitive processes.
• The increasing digitization of healthcare services and the integration of RPA with electronic health record and health IT platforms such as Epic and Cerner to auto-update records, manage scheduling, and synchronize data.
• The demand for compliance and audit readiness, since RPA maintains consistent documentation and audit trails and supports adherence to HIPAA, GDPR, and other regulatory frameworks.
• The convergence of RPA with artificial intelligence, machine learning, and natural language processing into intelligent automation and hyperautomation, extending bots to unstructured data and cognitive tasks.
• The growth of revenue cycle management automation, in which claims submission, denial prevention, and reimbursement optimization deliver measurable financial returns for providers.
• The shift toward cloud-based and low-code or no-code platforms, which lower the barrier to adoption and empower non-technical clinical and administrative staff to build automations.

Key Companies in RPA in Healthcare Market

The competitive landscape is led by the following active manufacturers:

• UiPath Inc.
• Automation Anywhere Inc.
• SS&C Blue Prism
• Pegasystems Inc.
• Microsoft Corporation
• International Business Machines Corporation
• NICE Ltd.
• WorkFusion Inc.
• Tungsten Automation (formerly Kofax)
• EdgeVerve Systems Limited (Infosys)

Factors Contributing to the Growth of the RPA in Healthcare Market

Market Drivers

Administrative Efficiency and Cost Reduction

The foundational driver of the RPA in healthcare market is the imperative to improve administrative efficiency and reduce operational cost, because healthcare is uniquely burdened with the high-volume, repetitive, rule-based administrative work that RPA is designed to eliminate. Hospitals and clinics are burdened with time-consuming administrative tasks such as data entry, claims processing, and billing, and RPA reduces manual workloads, cuts operational costs, and improves accuracy by having software bots perform these tasks continuously and without the errors that manual processing introduces. The financial pressure upon healthcare providers is intense and persistent, since margins are thin, administrative overhead is a large and growing share of total healthcare expenditure, and every error in billing or claims translates into delay, denial, or lost revenue, so an automation that reduces both cost and error addresses two of the most pressing problems facing every provider and payer simultaneously. The returns are measurable and often dramatic, with documented deployments reducing labor costs substantially and accelerating claims verification severalfold, and the scale of the addressable administrative workload means that even partial automation of a single process such as claims management or revenue cycle can justify the investment. Because administrative burden is universal across healthcare, because the financial pressure to reduce it is unrelenting, and because RPA delivers a rapid and quantifiable return, this driver provides the most durable foundation for market growth.

Healthcare Labor Shortages and Workforce Burnout

Healthcare labor shortages and workforce burnout are a powerful and distinctive driver of the RPA in healthcare market, because automation directly addresses the gap between the work that must be done and the workforce available to do it. The World Health Organization projects a shortfall of some 11 million health workers by 2030, concentrated in but not limited to low- and middle-income countries, and the staffing shortages that intensified after the COVID-19 pandemic have left healthcare organizations struggling to staff both clinical and administrative functions. RPA responds to this directly by deploying digital assistants to handle the repetitive administrative processes that would otherwise consume the time of scarce human workers, allowing those workers to focus on patient care and on the complex tasks that require human judgment. The burnout dimension is as important as the raw shortage, since a substantial part of clinician and administrative staff dissatisfaction arises from the burden of repetitive documentation, data entry, and administrative work, and shifting that burden to bots improves both retention and the quality of the work that remains. Because the workforce shortage is structural, long-term, and worsening as populations age and demand rises, and because RPA offers an immediate means of extending the capacity of the existing workforce, labor shortage is a central and durable driver of adoption.

Market Restraints

Despite a compelling efficiency case and rapid growth, the RPA in healthcare market faces several material constraints. The most significant is the concern regarding data security and privacy, since healthcare RPA bots handle sensitive protected health information, and the risks of breach, of non-compliance with data protection regulation, and of the ethical questions surrounding automation slow adoption in some areas, requiring that bots be configured with encryption, access controls, and secure integration, and that organizations satisfy themselves that automation does not expand the attack surface for sensitive data. A second and pervasive constraint is the difficulty of integration with legacy systems, since many hospitals still rely upon outdated information technology systems that lack application programming interfaces or interoperability, making the integration of RPA solutions more complex and costly. Although modern RPA can emulate the user interface where no formal integration exists, this approach introduces its own fragility. That fragility is itself a third constraint, since a bot interacts with underlying software through the user interface, and any change to that interface, such as a mandatory update to an electronic health record system, can break the programming of the bot immediately, requiring costly and time-consuming reconfiguration and creating a risk of operational downtime that necessitates robust governance, monitoring, and version control and adds an unavoidable overhead to the automation ecosystem. A fourth constraint is change management and workforce resistance, since the transition from manual to automated processes requires cultural change, staff training, and process redesign that can delay adoption in conservative healthcare environments, and since staff may perceive automation as a threat. Additional constraints include the high implementation and maintenance cost, which is a particular barrier for smaller providers and encompasses software licenses, development, customization, and integration, and the scarcity of the specialized skills required to design, deploy, and maintain automation at scale. Together, these security, integration, maintenance, organizational, and cost factors ensure that growth, while rapid, proceeds against genuine friction. Source: manufacturer disclosures; regulatory frameworks; peer-reviewed health informatics literature.

RPA in Healthcare Market Segment Analysis

The global RPA in healthcare market by type (software and services), by application (claims management, patient data management and electronic health record automation, revenue cycle management, billing and payment, appointment scheduling and registration, regulatory and compliance, and others), by end-user (healthcare providers, healthcare payers, pharmaceutical and life sciences companies, and others), and by geography (North America, Europe, Asia-Pacific, and the Rest of the World).

By Type

Dominant Subsegment: Software.

The software segment accounted for a 74% share of the RPA in healthcare market in 2025. Software dominates the type structure because the automation platform itself is the core of every RPA deployment and the element upon which the recurring license revenue that constitutes the majority of the market depends. Healthcare organizations increasingly rely upon licensed RPA software to automate high-volume, repetitive clinical and administrative workflows such as claims management, billing, and prior authorization, and the licensing model, in which a provider or payer pays for the software platform and the bots it runs, anchors the value of the market in the software layer. The integration of intelligent automation, in which software bots are enhanced with artificial intelligence and machine learning for cognitive tasks such as processing the unstructured data of clinical documentation, is solidifying the revenue contribution of the software segment by expanding the range and value of what the platform can automate. Services constitute the second type category and a rapidly growing one, encompassing the implementation, integration, support and maintenance, and training and consulting required to deploy and sustain automation, and this segment is the fastest growing component because the complexity of deploying RPA across legacy healthcare information technology systems, and of maintaining bots against the interface changes that break them, generates substantial and recurring demand for expert services. The two are complementary, since software creates the platform and services realize its value, but the software segment retains the leading share, reinforced by the shift toward artificial-intelligence-enhanced platforms. Software is expected to retain its leading share throughout the forecast period.

By Application

Dominant Subsegment: Claims Management.

The claims management segment accounted for a 33% share of the RPA in healthcare market in 2025. Claims management dominates the application structure because it is the highest-volume, most repetitive, and most financially consequential of the administrative processes that RPA automates, and because the return on automating it is immediate and measurable. Claims processing is a complex, multi-step workflow spanning data collection, claim creation, validation against payer-specific rules, submission, status tracking, and the handling of denials and resubmissions, and every stage is rule-based and error-prone, so automating it both reduces the cost of processing and reduces the denials and delays that erode provider revenue. The financial stakes are decisive, since a denied or delayed claim represents lost or deferred revenue, and RPA bots that validate claims before submission, catch the errors that would otherwise lead to denial, and automatically handle resubmission deliver a direct and quantifiable improvement in cash flow, which is why claims management and the broader revenue cycle constitute the leading entry point for RPA adoption. Patient data management and electronic health record automation form a substantial second application, automating the extraction, updating, transfer, and verification of clinical data across systems, and revenue cycle management, billing and payment, appointment scheduling and registration, and regulatory and compliance complete the application structure, each automating a distinct high-volume administrative process. The convergence of RPA with artificial intelligence is extending automation across all of these applications toward the unstructured and cognitive work they involve. Claims management is expected to retain its leading share throughout the forecast period.

RPA in Healthcare Market Region Analysis

Dominant Region: North America

North America accounted for a 40% share of the global RPA in healthcare market in 2025. The region led the market due to the high adoption of digital health infrastructure, a mature regulatory environment, and the presence of major RPA vendors including UiPath, Automation Anywhere, and Blue Prism. Healthcare providers in the United States and Canada are leveraging RPA to streamline billing, claims processing, and patient registration, and the region combines the largest and most digitized healthcare system in the world, in which electronic health record adoption is near universal, with the most intense administrative cost pressure and the deepest concentration of automation vendors and expertise. The complexity and cost of the United States healthcare reimbursement system, with its multiplicity of payers, its prior authorization requirements, and its high administrative overhead, creates an unusually strong incentive for revenue cycle and claims automation, and the documented deployments that demonstrate the value of RPA, from health system revenue cycle transformations to the automation of financial estimation and collections, are concentrated in the region. A mature regulatory environment, including the Health Insurance Portability and Accountability Act framework within which compliant automation operates, supports adoption, and the presence of the leading platform vendors ensures continuous innovation and implementation capacity. The region is expected to retain its leading position throughout the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is projected to register the fastest compound annual growth rate in the RPA in healthcare market through 2034. The region is emerging as a high-growth market, and the rapid digitization of hospitals, rising investment in artificial intelligence and automation, and government initiatives to modernize healthcare systems are fueling demand across the Asia-Pacific. The region combines very large and rapidly growing healthcare systems with an accelerating shift toward digital health infrastructure, and as hospitals across China, India, Japan, and South Korea digitize their records and operations, they create the digital substrate upon which RPA operates and the administrative workload that it automates. Government initiatives to modernize healthcare, expand coverage, and improve efficiency are channeling investment into health information technology and automation, and the combination of large populations, rising healthcare demand, and persistent workforce constraints makes the efficiency and capacity gains of RPA especially valuable. The rising investment in artificial intelligence and automation across the region positions it to adopt the intelligent-automation and cloud-based approaches that represent the frontier of the market, and both international vendors and capable regional providers are expanding to serve the opportunity. Because the region combines rapid digitization, large and growing healthcare systems, supportive government investment, and a low current base of automation, it is expected to grow faster than the mature markets over the forecast period. Regional growth is expected to exceed the global average across every segment.

Regional Commentary

North America

North America leads on value and adoption, holding a 40% share in 2025. The region leads through high adoption of digital health infrastructure, a mature regulatory environment, and the presence of the major RPA vendors including UiPath, Automation Anywhere, and Blue Prism. The complexity and administrative cost of the United States reimbursement system create an unusually strong incentive for claims and revenue cycle automation, and the documented health system deployments that demonstrate the value of RPA are concentrated in the region. Near-term dynamics are shaped by the convergence of RPA with artificial intelligence, the growth of revenue cycle automation, cloud and low-code adoption, and the intense administrative cost pressure upon providers and payers.

Europe

Europe is a substantial and high-growth market, and the emphasis upon reducing healthcare costs, an aging population, and strong data privacy regulation such as the General Data Protection Regulation are encouraging providers to implement secure RPA solutions. The region combines large, mostly public healthcare systems under sustained cost pressure with advanced digitization in several countries, and documented deployments in the United Kingdom National Health Service, automating patient registration, scheduling, and referral management, illustrate the value of RPA in a public health system context. The stringent European data protection framework shapes adoption toward secure and compliant automation and favors vendors able to demonstrate rigorous governance, while public procurement and budget constraints influence the pace and scale of deployment across Germany, the United Kingdom, France, and the other principal markets.

Asia-Pacific

Asia-Pacific is the fastest-growing region, and the rapid digitization of hospitals, rising investment in artificial intelligence and automation, and government initiatives to modernize healthcare systems are fueling demand. The region combines very large and rapidly growing healthcare systems across China, India, Japan, and South Korea with an accelerating shift toward digital health infrastructure, and government modernization initiatives are channeling investment into health information technology and automation. Large populations, rising healthcare demand, and persistent workforce constraints make the efficiency and capacity gains of RPA especially valuable, and both international and regional vendors are expanding to serve the opportunity. Growth exceeds the global average across every segment.

Rest of World

The Rest of the World comprises the Middle East, Africa, and South America. Adoption is stratified. The Gulf states are investing heavily in digital health infrastructure and hospital modernization as part of broader economic diversification, and the larger Latin American markets, particularly Brazil, support growing private healthcare systems that are adopting automation, together representing steady growth. Much of Africa has limited digital health infrastructure and constrained information technology budgets, so RPA adoption is concentrated in the larger private systems and the more digitized markets. Regional growth will be driven by investment in digital health infrastructure, the modernization of hospital operations, the rising administrative burden of expanding healthcare systems, and the availability of cloud-based automation that lowers the barrier to adoption.

RPA in Healthcare Market Competitive Landscape

The global RPA in healthcare market is classified as Moderately Concentrated. The market is led by the major horizontal enterprise automation platforms, whose healthcare offerings hold a substantial combined share, complemented by intelligent-automation and document-processing specialists and by a growing tier of healthcare-specific automation and revenue cycle vendors. Competition centers upon the breadth and intelligence of the automation platform, the depth of pre-built healthcare templates and integrations, the strength of electronic health record and health IT integration, security and regulatory compliance, and increasingly upon the convergence of RPA with artificial intelligence into intelligent automation. The competitive landscape is evaluated across the following dimensions:

• Market concentration: Moderately concentrated, with the major horizontal automation platforms holding a substantial combined share alongside intelligent-automation specialists and a growing tier of healthcare-specific vendors, and with the scale, platform breadth, and integration depth of the leaders constituting a barrier to entry.
• Leading players: UiPath, Automation Anywhere, SS&C Blue Prism, and Pegasystems lead the healthcare RPA market through broad and increasingly AI-enabled automation platforms, with Microsoft and IBM competing through enterprise automation and artificial intelligence portfolios, and NICE, WorkFusion, Tungsten Automation, and EdgeVerve contesting intelligent-automation, document-processing, and services-led segments.
• Geographic reach: The leading platform vendors maintain global commercial, partner, and implementation networks, which matter because healthcare RPA requires local integration, compliance, and support, while healthcare-specific and revenue cycle vendors concentrate upon the markets, notably the United States, where the administrative complexity that they address is greatest.
• Product portfolio strength: Competitive advantage rests upon the breadth and intelligence of the platform, the depth of pre-built healthcare bots and templates for claims, billing, scheduling, and prior authorization, and the strength of integration with electronic health record and health IT systems, since healthcare buyers value a platform that addresses their specific workflows out of the box and integrates with their existing systems.
• Pipeline strength: Development is concentrated in the fusion of RPA with artificial intelligence, machine learning, and natural language processing for cognitive and unstructured-data automation, in agentic and hyperautomation platforms, in process mining, in cloud-based and low-code delivery, and in healthcare-specific intelligent automation.
• Strategic partnerships: Collaboration spans partnerships between platform vendors and health systems, payers, and revenue cycle organizations to deploy automation at scale, exemplified by multi-year automation programs transforming revenue cycle operations, alongside alliances with electronic health record vendors, system integrators, and cloud providers.
• M&A activity: Consolidation has reshaped the field, exemplified by the acquisition of Blue Prism by SS&C and the rebranding of Kofax as Tungsten Automation, and major software and services companies continue to acquire intelligent-automation, document-processing, and healthcare-specific capabilities to complete their platforms.
• Innovation focus: Innovation is shifting toward agentic and generative artificial intelligence integrated with RPA, the automation of unstructured clinical data, end-to-end hyperautomation across the patient journey, process mining, cloud-native and low-code delivery, and healthcare-specific intelligent automation for revenue cycle and clinical workflows.
• Regulatory standing: The ability to operate in compliance with healthcare data protection frameworks including the Health Insurance Portability and Accountability Act and the General Data Protection Regulation, with the security, audit trails, and access controls they require, is a decisive competitive credential, and the handling of protected health information makes demonstrated security and compliance a prerequisite for adoption.

RPA in Healthcare Market Recent Developmental Activities

In early 2025, Omega Healthcare expanded its partnership with UiPath to automate over 100 million annual transactions in revenue cycle management, achieving a 50% reduction in processing time and 99.5% data accuracy. Strategic significance: an automation program operating at the scale of over 100 million annual transactions demonstrated the enterprise-grade capability of healthcare RPA in the revenue cycle, the largest application, and it validated the measurable financial and accuracy returns that anchor adoption.

RPA in Healthcare Market Segmentation

RPA in Healthcare Market Assessment by Type

• Software
• Services

RPA in Healthcare Market Assessment by Application

• Claims Management
• Patient Data Management and EHR Automation
• Revenue Cycle Management
• Billing and Payment
• Appointment Scheduling and Registration
• Regulatory and Compliance
• Others

RPA in Healthcare Market Assessment by End-User

• Healthcare Providers
• Healthcare Payers
• Pharmaceutical and Life Sciences Companies
• Others

RPA in Healthcare Market Assessment by Geography

• North America
• United States RPA in Healthcare Market Size in USD million (2023-2034)
• Canada RPA in Healthcare Market Size in USD million (2023-2034)
• Mexico RPA in Healthcare Market Size in USD million (2023-2034)
• Europe
• France RPA in Healthcare Market Size in USD million (2023-2034)
• Germany RPA in Healthcare Market Size in USD million (2023-2034)
• United Kingdom RPA in Healthcare Market Size in USD million (2023-2034)
• Italy RPA in Healthcare Market Size in USD million (2023-2034)
• Spain RPA in Healthcare Market Size in USD million (2023-2034)
• Rest of Europe RPA in Healthcare Market Size in USD million (2023-2034)
• Asia-Pacific
• China RPA in Healthcare Market Size in USD million (2023-2034)
• Japan RPA in Healthcare Market Size in USD million (2023-2034)
• India RPA in Healthcare Market Size in USD million (2023-2034)
• Australia RPA in Healthcare Market Size in USD million (2023-2034)
• South Korea RPA in Healthcare Market Size in USD million (2023-2034)
• Rest of Asia-Pacific RPA in Healthcare Market Size in USD million (2023-2034)
• Rest of the World
• Middle East RPA in Healthcare Market Size in USD million (2023-2034)
• Africa RPA in Healthcare Market Size in USD million (2023-2034)
• South America RPA in Healthcare Market Size in USD million (2023-2034)

Frequently Asked Questions:

Q1. At what rate is the RPA in healthcare market expected to grow?

The global Robotic Process Automation (RPA) in healthcare market is projected to grow at a compound annual growth rate of 20.37% during the forecast period from 2026 to 2034.

Q2. What is the current and projected size of the RPA in healthcare market?

The global Robotic Process Automation (RPA) in healthcare market was valued at USD 2,745.12 million in 2025 and is projected to reach USD 14,562.17 million by 2034.

Q3. Which region dominates the RPA in healthcare market?

North America dominated the Robotic Process Automation (RPA) in healthcare market with a 40% share in 2025, and the region led due to the high adoption of digital health infrastructure, a mature regulatory environment, and the presence of the major RPA vendors including UiPath, Automation Anywhere, and Blue Prism, with healthcare providers in the United States and Canada leveraging RPA to streamline billing, claims processing, and patient registration. Asia-Pacific is projected to record the fastest compound annual growth rate through 2034, driven by the rapid digitization of hospitals, rising investment in artificial intelligence and automation, and government initiatives to modernize healthcare systems.

Q4. What are the key factors driving growth in the RPA in healthcare market?

The principal drivers are the rising need for administrative efficiency and cost reduction in a sector burdened with repetitive data entry, claims processing, and billing; healthcare labor shortages and burnout, with the World Health Organization projecting a shortfall of some 11 million health workers by 2030; the digitization of healthcare and integration with electronic health record platforms; the demand for compliance and audit readiness under HIPAA and GDPR; the convergence of RPA with artificial intelligence into intelligent automation and hyperautomation; the growth of revenue cycle management automation; and the shift toward cloud-based and low-code platforms.

Q5. Who are the major players in the RPA in healthcare market?

The market is moderately concentrated and led by UiPath Inc., Automation Anywhere Inc., SS&C Blue Prism, and Pegasystems Inc., whose healthcare automation platforms hold a substantial combined share, alongside Microsoft Corporation and International Business Machines Corporation competing through enterprise automation and artificial intelligence portfolios, and NICE Ltd., WorkFusion Inc., Tungsten Automation (formerly Kofax), and EdgeVerve Systems Limited (Infosys) in intelligent-automation and services-led segments. Additional participants include AutomationEdge, Nividous, Cigniti Technologies, Notable Health, Thoughtful AI, Waystar, FinThrive, NextGen Healthcare, and CloudMedx.

Table of Contents

1. RPA in Healthcare Market Introduction

• 1.1. Scope of the Report
• 1.2. Market Segmentation
• 1.3. Market Overview at a Glance

2. RPA in Healthcare Market Executive Summary

• 2.1. Key Highlights and Market Snapshot

3. RPA in Healthcare Market Key Factors Analysis

• 3.1. Market Drivers
  • 3.1.1. Administrative Efficiency and Cost Reduction
  • 3.1.2. Healthcare Labor Shortages and Workforce Burnout
  • 3.1.3. Digitization of Healthcare and EHR Integration
  • 3.1.4. Convergence with Artificial Intelligence and Hyperautomation
• 3.2. Market Restraints
  • 3.2.1. Data Security and Privacy Concerns
  • 3.2.2. Integration with Legacy Systems and Bot Fragility
  • 3.2.3. Change Management and Implementation Cost
• 3.3. Market Opportunities
  • 3.3.1. Intelligent Automation and Revenue Cycle Management
  • 3.3.2. Cloud, Low-Code, and Emerging Markets

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

• 5.1. The United States
• 5.2. Europe
• 5.3. Japan
• 5.4. China

6. RPA in Healthcare Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. RPA in Healthcare Market Assessment

• 7.1. By Type
  • 7.1.1. Software
  • 7.1.2. Services
• 7.2. By Application
  • 7.2.1. Claims Management
  • 7.2.2. Patient Data Management and EHR Automation
  • 7.2.3. Revenue Cycle Management
  • 7.2.4. Billing and Payment
  • 7.2.5. Appointment Scheduling and Registration
  • 7.2.6. Regulatory and Compliance
  • 7.2.7. Others
• 7.3. By End-User
  • 7.3.1. Healthcare Providers
  • 7.3.2. Healthcare Payers
  • 7.3.3. Pharmaceutical and Life Sciences Companies
  • 7.3.4. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.1.2. Canada RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.1.3. Mexico RPA in Healthcare Market Size in USD million (2023-2034)
  • 7.4.2. Europe
    • 7.4.2.1. France RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.2.2. Germany RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.2.3. United Kingdom RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.2.4. Italy RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.2.5. Spain RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.2.6. Rest of Europe RPA in Healthcare Market Size in USD million (2023-2034)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.3.2. Japan RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.3.3. India RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.3.4. Australia RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.3.5. South Korea RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.3.6. Rest of Asia-Pacific RPA in Healthcare Market Size in USD million (2023-2034)
  • 7.4.4. Rest of the World
    • 7.4.4.1. Middle East RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.4.2. Africa RPA in Healthcare Market Size in USD million (2023-2034)
    • 7.4.4.3. South America RPA in Healthcare Market Size in USD million (2023-2034)

8. RPA in Healthcare Market Competitive Landscape

• 8.1. Competitive Analysis
• 8.2. Company Share Analysis (Premium Offering)

9. RPA in Healthcare Market Startup Funding and Investment Trends

10. RPA in Healthcare Market Company and Product Profiles

• 10.1. UiPath Inc.
  • 10.1.1. Company Overview
  • 10.1.2. Company Snapshot
  • 10.1.3. Financial Overview
  • 10.1.4. Product Listing
  • 10.1.5. Strategic Initiatives / Entropy
• 10.2. Automation Anywhere Inc.
  • 10.2.1. Company Overview
  • 10.2.2. Company Snapshot
  • 10.2.3. Financial Overview
  • 10.2.4. Product Listing
  • 10.2.5. Strategic Initiatives / Entropy
• 10.3. SS&C Blue Prism
  • 10.3.1. Company Overview
  • 10.3.2. Company Snapshot
  • 10.3.3. Financial Overview
  • 10.3.4. Product Listing
  • 10.3.5. Strategic Initiatives / Entropy
• 10.4. Pegasystems Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Snapshot
  • 10.4.3. Financial Overview
  • 10.4.4. Product Listing
  • 10.4.5. Strategic Initiatives / Entropy
• 10.5. Microsoft Corporation
  • 10.5.1. Company Overview
  • 10.5.2. Company Snapshot
  • 10.5.3. Financial Overview
  • 10.5.4. Product Listing
  • 10.5.5. Strategic Initiatives / Entropy
• 10.6. International Business Machines Corporation
  • 10.6.1. Company Overview
  • 10.6.2. Company Snapshot
  • 10.6.3. Financial Overview
  • 10.6.4. Product Listing
  • 10.6.5. Strategic Initiatives / Entropy
• 10.7. NICE Ltd.
  • 10.7.1. Company Overview
  • 10.7.2. Company Snapshot
  • 10.7.3. Financial Overview
  • 10.7.4. Product Listing
  • 10.7.5. Strategic Initiatives / Entropy
• 10.8. WorkFusion Inc.
  • 10.8.1. Company Overview
  • 10.8.2. Company Snapshot
  • 10.8.3. Financial Overview
  • 10.8.4. Product Listing
  • 10.8.5. Strategic Initiatives / Entropy
• 10.9. Tungsten Automation (formerly Kofax)
  • 10.9.1. Company Overview
  • 10.9.2. Company Snapshot
  • 10.9.3. Financial Overview
  • 10.9.4. Product Listing
  • 10.9.5. Strategic Initiatives / Entropy
• 10.10. EdgeVerve Systems Limited (Infosys)
  • 10.10.1. Company Overview
  • 10.10.2. Company Snapshot
  • 10.10.3. Financial Overview
  • 10.10.4. Product Listing
  • 10.10.5. Strategic Initiatives / Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us